Recurrent Melanoma Completed Phase 1 Trials for Modafinil (DB00745)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02574533Pilot Study of Vigilâ„¢ + Pembrolizumab for Advanced MelanomaTreatment